1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

The pathophysiology of motor fatigue and fatigability in multiple sclerosis, 2022, Robert Patejdl

Discussion in 'Other health news and research' started by Mij, Aug 16, 2022.

  1. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    8,330
    Multiple Sclerosis (MS) is a heterogeneous immune mediated disease of the central nervous system (CNS). Fatigue is one of the most common and disabling symptom of MS. It interferes with daily activities on the level of cognition and motor endurance. Motor fatigue can either result from lesions in cortical networks or motor pathways (“primary fatigue”) or it may be a consequence of detraining with subsequent adaptions of muscle and autonomic function.

    Programmed exercise interventions are used frequently to increase physical fitness in MS patients. Studies investigating the effects of training on aerobic capacity, objective endurance and perceived fatigability have yielded heterogenous results, most likely due to the heterogeneity of interventions and patients, but probably also due to the non-uniform
    pathophysiology of fatigability among MS-patients.

    The aim of this review is to summarize the current knowledge on the pathophysiology of motor fatigability with special reference to the basic exercise physiology that underlies our understanding of both pathogenesis and treatment interventions.

    https://www.frontiersin.org/articles/10.3389/fneur.2022.891415/full
     

Share This Page